Human Genome (HGSI) volatility decreases into GlaxoSmithKline’s July 20 expiration of tender

Human Genome (Nasdaq: HGSI) overall option implied volatility of 44 is below its 26-week average of 74 into GlaxoSmithKline (NYSE: GSK) setting July 20 for the $13/sh tender offer for the company.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Norwegian Cruise Line (NCLH) call put ratio 1 call to 2.4 puts amid price movement
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put